← Back to All US Stocks

Tenet Healthcare Corp. (THC) Stock Fundamental Analysis & AI Rating 2026

THC NYSE Services-General Medical & Surgical Hospitals, NEC NV CIK: 0000070318
Recently Updated • Analysis: Apr 17, 2026 • SEC Data: 2025-12-31
HOLD
70% Conf
Pending
Analysis scheduled

📊 THC Key Takeaways

Revenue: $21.3B
Net Margin: 6.6%
Free Cash Flow: $2.5B
Current Ratio: 1.76x
Debt/Equity: 3.10x
EPS: $15.49
AI Rating: HOLD with 70% confidence
Tenet Healthcare Corp. (THC) receives a HOLD rating with 70% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $21.3B, net profit margin of 6.6%, and return on equity (ROE) of 33.3%, Tenet Healthcare Corp. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete THC stock analysis for 2026.

Is Tenet Healthcare Corp. (THC) a Good Investment?

Claude

Tenet Healthcare exhibits solid cash generation fundamentals with $2.5B free cash flow and strong 16.1x interest coverage, supporting a leveraged balance sheet. However, a sharp 40.6% decline in net income and 52.6% EPS decline—despite stable operating income—signals underlying operational or non-operating pressures that require clarification before investment.

Why Buy Tenet Healthcare Corp. Stock? THC Key Strengths

Claude
  • + Strong free cash flow of $2.5B with 11.9% FCF margin demonstrates operational cash conversion quality
  • + Excellent interest coverage ratio of 16.1x provides substantial debt service safety despite $13.1B long-term debt
  • + Healthy liquidity with 1.76x current ratio and 1.68x quick ratio ensures near-term financial flexibility
  • + Operating income of $3.5B aligns with operating cash flow, confirming high-quality earnings from core business

THC Stock Risks: Tenet Healthcare Corp. Investment Risks

Claude
  • ! Net income collapse of 40.6% YoY with EPS down 52.6% indicates significant below-operating-line deterioration despite stable operating performance
  • ! High leverage at 3.10x debt-to-equity ratio magnifies impact of earnings volatility on shareholder value
  • ! Modest 3.1% revenue growth combined with declining net profitability suggests pricing pressure or cost inflation not offset by volume growth

Key Metrics to Watch

Claude
  • * Net income trend and drivers of year-over-year decline to determine if issue is structural or non-recurring
  • * Operating cash flow sustainability relative to capital expenditure needs to monitor free cash flow trajectory
  • * Debt reduction progress and debt-to-EBITDA ratio movement given high absolute leverage

Tenet Healthcare Corp. (THC) Financial Metrics & Key Ratios

Revenue
$21.3B
Net Income
$1.4B
EPS (Diluted)
$15.49
Free Cash Flow
$2.5B
Total Assets
$29.7B
Cash Position
$2.9B

💡 AI Analyst Insight

Tenet Healthcare Corp. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.

THC Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin 16.5%
Net Margin 6.6%
ROE 33.3%
ROA 4.7%
FCF Margin 11.9%

THC vs Healthcare Sector: How Tenet Healthcare Corp. Compares

How Tenet Healthcare Corp. compares to Healthcare sector averages

Net Margin
THC 6.6%
vs
Sector Avg 12.0%
THC Sector
ROE
THC 33.3%
vs
Sector Avg 15.0%
THC Sector
Current Ratio
THC 1.8x
vs
Sector Avg 2.0x
THC Sector
Debt/Equity
THC 3.1x
vs
Sector Avg 0.6x
THC Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Tenet Healthcare Corp. Stock Overvalued? THC Valuation Analysis 2026

Based on fundamental analysis, Tenet Healthcare Corp. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
33.3%
Sector avg: 15%
Net Profit Margin
6.6%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
3.10x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Tenet Healthcare Corp. Balance Sheet: THC Debt, Cash & Liquidity

Current Ratio
1.76x
Quick Ratio
1.68x
Debt/Equity
3.10x
Debt/Assets
69.8%
Interest Coverage
16.09x
Long-term Debt
$13.1B

THC Revenue & Earnings Growth: 5-Year Financial Trend

THC 5-year financial data: Year 2021: Revenue $19.5B, Net Income $171.0M, EPS $-2.08. Year 2022: Revenue $19.5B, Net Income $768.0M, EPS $3.75. Year 2023: Revenue $20.5B, Net Income $1.5B, EPS $8.42. Year 2024: Revenue $20.7B, Net Income $1.0B, EPS $3.79. Year 2025: Revenue $21.3B, Net Income $1.3B, EPS $5.71.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Tenet Healthcare Corp.'s revenue has shown modest growth of 9% over the 5-year period. The most recent EPS of $5.71 reflects profitable operations.

THC Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
11.9%
Free cash flow / Revenue

THC Quarterly Earnings & Performance

Quarterly financial performance data for Tenet Healthcare Corp. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $5.1B $579.0M $3.86
Q2 2025 $5.1B $477.0M $2.64
Q1 2025 $5.2B $622.0M $4.27
Q3 2024 $5.1B $266.0M $0.94
Q2 2024 $5.1B $293.0M $1.15
Q1 2024 $5.0B $296.0M $1.32
Q3 2023 $4.8B $266.0M $0.94
Q2 2023 $4.6B $179.0M $0.35

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Tenet Healthcare Corp. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
$3.5B
Cash generated from operations
Stock Buybacks
$1.4B
Shares repurchased (TTM)
Capital Expenditures
$1.0B
Investment in assets
Dividends
None
No dividend program

THC SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Tenet Healthcare Corp. (CIK: 0000070318)

📋 Recent SEC Filings

Date Form Document Action
Apr 16, 2026 DEF 14A d928614ddef14a.htm View →
Apr 10, 2026 8-K thc-20260409.htm View →
Mar 30, 2026 8-K thc-20260325.htm View →
Mar 13, 2026 4 xslF345X05/ownership.xml View →
Mar 10, 2026 4 xslF345X05/ownership.xml View →

Frequently Asked Questions about THC

What is the AI rating for THC?

Tenet Healthcare Corp. (THC) has an AI rating of HOLD with 70% confidence, based on fundamental analysis of SEC EDGAR filings.

What are THC's key strengths?

Claude: Strong free cash flow of $2.5B with 11.9% FCF margin demonstrates operational cash conversion quality. Excellent interest coverage ratio of 16.1x provides substantial debt service safety despite $13.1B long-term debt.

What are the risks of investing in THC?

Claude: Net income collapse of 40.6% YoY with EPS down 52.6% indicates significant below-operating-line deterioration despite stable operating performance. High leverage at 3.10x debt-to-equity ratio magnifies impact of earnings volatility on shareholder value.

What is THC's revenue and growth?

Tenet Healthcare Corp. reported revenue of $21.3B.

Does THC pay dividends?

Tenet Healthcare Corp. does not currently pay dividends.

Where can I find THC SEC filings?

Official SEC filings for Tenet Healthcare Corp. (CIK: 0000070318) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is THC's EPS?

Tenet Healthcare Corp. has a diluted EPS of $15.49.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is THC a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Tenet Healthcare Corp. has a HOLD rating with 70% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is THC stock overvalued or undervalued?

Valuation metrics for THC: ROE of 33.3% (sector avg: 15%), net margin of 6.6% (sector avg: 12%). Higher ROE suggests strong returns relative to peers.

Should I buy THC stock in 2026?

Our dual AI analysis gives Tenet Healthcare Corp. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is THC's free cash flow?

Tenet Healthcare Corp.'s operating cash flow is $3.5B, with capital expenditures of $1.0B. FCF margin is 11.9%.

How does THC compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin 6.6% (avg: 12%), ROE 33.3% (avg: 15%), current ratio 1.76 (avg: 2).

Is Tenet Healthcare Corp. carrying too much debt?

THC has a debt-to-equity ratio of 3.10x, which is above the Healthcare sector average of 0.6x. However, the current ratio of 1.76 suggests adequate short-term liquidity.

Why is THC's return on equity (ROE) so high?

Tenet Healthcare Corp. has a return on equity of 33.3%, significantly above the Healthcare sector average of 15%. A high ROE indicates the company is efficient at generating profits from shareholder equity. This is supported by a 6.6% net margin.

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Browse: High ROE Stocks
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 17, 2026 | Data as of: 2025-12-31 | Powered by Claude AI